Fereshteh Asgari
- Endocrinology, Diabetes and Metabolism top 2%
- Public Health, Environmental and Occupational Health top 5%
- Epidemiology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Physiology top 10%
- Co-authors
- Alireza EsteghamatiMehrdad HaghazaliMehrshad AbbasiAlipasha MeysamieOmid KhalilzadehArmin RashidiJalil KoohpayehzadehManouchehr Nakhjavani
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers)Health Promotion and Cardiovascular Prevention (9 papers)Obesity, Physical Activity, Diet (9 papers)
- Cited by
- Endocrinology, Diabetes and MetabolismPublic Health, Environmental and Occupational HealthPharmacy
- Journals
- SHILAP Revista de lepidopterologíaBMC Public HealthPreventive Medicine
- Partner nations
- IranUnited StatesUnited Kingdom
In The Last Decade
Fereshteh Asgari
40 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 118
- Endocrinology, Diabetes and Metabolism 481
- Public Health, Environmental and Occupational Health 465
- Epidemiology 303
- Cardiology and Cardiovascular Medicine 278
- Physiology 272
Countries citing papers authored by Fereshteh Asgari
This map shows the geographic impact of Fereshteh Asgari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fereshteh Asgari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fereshteh Asgari more than expected).
Fields of papers citing papers by Fereshteh Asgari
This network shows the impact of papers produced by Fereshteh Asgari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fereshteh Asgari. The network helps show where Fereshteh Asgari may publish in the future.
Co-authorship network of co-authors of Fereshteh Asgari
This figure shows the co-authorship network connecting the top 25 collaborators of Fereshteh Asgari. A scholar is included among the top collaborators of Fereshteh Asgari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fereshteh Asgari. Fereshteh Asgari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 17 | |
| 3 | Distributions of High-Sensitivity C-Reactive Protein, Total Cholesterol-HDL Ratio and 10-Year Cardiovascular Risk: National Population-Based Study. | 5 |
| 4 | Zero and Five End-Digit Preference and Blood Pressure Quality of Care Revisited. | 3 |
| 5 | 10 | |
| 6 | Awareness, Treatment and Control of Pre-hypertension and Hypertension among Adults in Iran. | 38 |
| 7 | Oral Hygiene Status in a General Population of Iran, 2011: A Key Lifestyle Marker in Relation to Common Risk Factors of Non-Communicable Diseases | 3 |
| 8 | 20 | |
| 9 | 22 | |
| 10 | 58 | |
| 11 | 12 | |
| 12 | Serum cholesterol level nomograms for Iranian population; suggestion for national cut-offs. | 3 |
| 13 | Trend of Blood Cholesterol Level in Iran: Results of Four National Surveys During 1991-2008 | 7 |
| 14 | Housewives ’ Obesity Determinant Factors in Iran; National Survey- Stepwise Approach to Surveillance | 4 |
| 15 | 170 | |
| 16 | 22 | |
| 17 | 74 | |
| 18 | Non-Communicable Diseases Risk Factors Surveillance in Iran | 44 |
| 19 | 30 | |
| 20 | COMPARISON OF DISC DIFFUSION AND E TEST METHODS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING OF VANCOMYCIN IN COAGULASE NEGATIVE STAPHYLOCOCCUS ISOLATED FROM BLOOD CULTURE | 4 |
About Fereshteh Asgari
Fereshteh Asgari is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacy and Public Health, Environmental and Occupational Health, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Health Promotion and Cardiovascular Prevention (9 papers) and Obesity, Physical Activity, Diet (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (481 citations), Public Health, Environmental and Occupational Health (465 citations) and Pharmacy (63 citations). Fereshteh Asgari has collaborated with scholars based in Iran, United States and United Kingdom. Frequent co-authors include Alireza Esteghamati, Mehrdad Haghazali, Mehrshad Abbasi, Alipasha Meysamie, Omid Khalilzadeh, Armin Rashidi, Jalil Koohpayehzadeh, Manouchehr Nakhjavani, Ali Rafei and Koorosh Etemad. Their work appears in journals such as SHILAP Revista de lepidopterología, BMC Public Health and Preventive Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.